|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/496 | |||
| A61P 35/00 |
| (11) | Number of the document | 3290414 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17192138.0 |
| Date of filing the European patent application | 2013-05-22 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 12169139 | 2012-05-23 | EP |
| (72) |
BARBUGIAN, Natale Alvaro, IT
FORINO, Romualdo, IT
FUMAGALLI, Tiziano, IT
ORSINI, Paolo, IT
|
| (73) |
NERVIANO MEDICAL SCIENCES S.R.L.,
Viale Pasteur, 10, 20014 Nerviano (MI),
IT
|
| (54) | CRYSTALLINE FORM OF N-[5-(3,5-DIFLUORO-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMIDE |
| CRYSTALLINE FORM OF N-[5-(3,5-DIFLUORO-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMIDE |